Overview Sertraline Hydrochloride 100 mg Tablets, Fasting Status: Completed Trial end date: 2002-04-01 Target enrollment: Participant gender: Summary The objective of this study is to compare the rate and extent of absorption of sertraline hydrochloride 100 mg tablets (test) versus Zoloft® (reference) administered as 1 x 100 mg tablet under fasting conditions. Phase: Phase 1 Details Lead Sponsor: Teva Pharmaceuticals USATreatments: Sertraline